Huron (HURN) director reports 2,000-share sale at ~$137 under 10b5-1 plan
Rhea-AI Filing Summary
James H. Roth, a director of Huron Consulting Group Inc. (HURN), reported two open-market sales on 09/02/2025 totaling 2,000 shares executed pursuant to a Rule 10b5-1 trading plan. The sales were reported as 506 shares at a weighted average price of $136.99 and 1,494 shares at a weighted average price of $137.68, reflecting transaction price ranges detailed in the filing. After these transactions Mr. Roth beneficially owned 41,304 shares directly and 3,855 shares indirectly through a family LLC. The Form 4 was signed by an attorney-in-fact and includes an undertaking to provide detailed per-price sale information on request.
Positive
- Sales executed under a Rule 10b5-1 plan, reducing likelihood of timing-based inference
- Filing discloses weighted-average prices and price ranges and offers to provide per-price details on request
- Clear post-transaction ownership disclosure showing direct and indirect holdings
Negative
- Insider sold 2,000 shares, which may be viewed negatively by some investors as insider liquidity
- Sale reduces direct holdings from previously higher levels to 41,304 shares (direct)
Insights
TL;DR: Director sold a small portion of holdings under a 10b5-1 plan; transactions are routine insider liquidity, not a material corporate event.
The reported sale of 2,000 shares on 09/02/2025 was executed under a pre-established Rule 10b5-1 plan, which reduces timing-based inference about intent. Sale prices (weighted averages $136.99 and $137.68) and the aggregate size relative to reported post-sale holdings (41,304 direct shares) indicate this is modest insider disposition rather than a control change or large divestiture. Disclosure includes an undertaking to provide per-price detail, supporting transparency. No derivatives or other compensatory transactions were reported.
TL;DR: Reporting follows Section 16 requirements and notes use of a 10b5-1 plan, demonstrating procedural compliance.
The Form 4 clearly identifies the reporting person as a director and marks the sales as pursuant to a written 10b5-1 plan adopted May 8, 2025, which provides an affirmative defense under Rule 10b5-1(c). The filing is signed by an attorney-in-fact and includes explanatory footnotes about price ranges. From a governance perspective, documentation and willingness to supply detailed per-price sale information on request are positive compliance signals. There are no indications of contemporaneous related-party or derivative transactions in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 506 | $136.99 | $69K |
| Sale | Common Stock | 1,494 | $137.68 | $206K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The reported sale of 2,000 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a range of $136.39 - $137.36 for the sale of 506 shares and a range of $137.41 - $138.12 for the sale of 1,494 shares. The undersigned undertakes to provide Huron Consulting Group Inc. ("Huron"), any security holder of Huron or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
